Publication | Open Access

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Metabolic SyndromeDiabetes ManagementAlogliptin And/or PioglitazoneCardiovascular DiseaseMedicineInsulin ManagementDiabetesType 2Postprandial LipidsDiabetes MellitusPharmacologyDyslipidemia